Feb 16, 2026

An article on Barchart details the recent performance and analyst sentiment for Henry Schein, Inc. The company, a provider of health care products and services, has a market capitalization of $9.2 billion and operates globally. Its stock, trading under the ticker HSIC, has underperformed the broader market over the past year but has seen slight outperformance so far in 2026. Specifically, HSIC has grown marginally over the past 52 weeks and is up 3.5% year-to-date. In contrast, the S&P 500 Index, referred to as $SPX, returned 11.8% over the past year and has declined marginally in 2026.

Compared to the healthcare sector, HSIC has underperformed the State Street Healthcare Select Sector SPDR…